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Mouse-human somatic cell hybrids have been used in a number of studies to demon- 
strate that particular human genes are syntenic and that they are linked to a specific 
human chromosome. The reason for using mouse-human  cell hybrids lies in the prefer- 
ential loss  of human chromosomes,  that certain mouse and human phenotypes are 
distinguishable from each other,  and that the human chromosomes are identifiable 
from the mouse chromosomes in the hybrid cells (1, 2). 
When two or more human phenotypes are always present together in a hybrid cell 
population, never one without the other, and if both are lost together, then one can 
infer that they are syntenic (present on the same chromosome). This is also referred to 
as concordant segregation. However,  when two or more human phenotypes in the 
hybrid cell population are present, sometimes one without the other,  then they are 
asyntenic. This is referred to as discordant segregation. Furthermore, if the presence of 
one or more human phenotypes always correlates with the presence of a particular 
human chromosome, and if the phenotype(s) is (are) lost together with the loss of that 
particular chromosome,  then one can infer that the particular gene(s)  is (are)  linked 
to that chromosome. 
In this paper, using the technique of mouse-human somatic cell hybridization 
and the rationale just described, we have been able to demonstrate the concord- 
ant segregation of the human dimeric  form  of  indophenol oxidase  (IPO-B)  1 
and  antiviral protein  (AVP)  induced by human interferon.  Thus,  we  have 
demonstrated the  two  human functions are  syntenic. Furthermore,  we  have 
been able to provide evidence which indicates that both functions are linked to 
the human G-21 chromosome. 
Materials and Methods 
Cell Hybridization and Culture Methods.--Hybrid  cell populations were produced by mixing 
mouse and human cells together, in either a 1:4 or 1  : 10 human to mouse cell ratio at a total 
cell density of 4 X l0  s cells/25 cm  2 Falcon (Oxnard, Calif.) tissue culture flask (3). Cell fusion 
1  Abbreviations used in this paper: APRT, adenine phosphoribosyltransferase; AVP, anti- 
viral protein; CPE, cytopathic effect; DVME, Dulbecco-Vogt modified Eagle's minimal me- 
dium; IPO-B, iudophenol oxidase-b; MOI, multiplicity of infection; NDV, Newcastle disease 
virus; VSV, vesicular stomatitis virus. 
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was stimulated by the addition of B-propiolactone-inactivated (1 ml) Sendal virus at concen- 
trations of 1,000 hemagglutination units/ml (3, 4). In the case where both parent cells were 
fibroblasts, fusion was performed with the cells in monolayer. In those hybrids which were 
formed from a human leukocyte parent and a mouse fibroblast, fusion was performed with the 
cells in suspension (5). 
The following three hybrid series were analyzed in this study.  Wa  hybrids were formed 
between  mouse  A9  cells  deficient in  adenine  phosphoribosyltransferase  (APRT)  and  the 
normal human female fibroblastic cell strain WI38. JBA hybrids were formed between A9 
cells deficient in APRT and human leukocytes, JB, which carry a heterozygous 14/4 2 centric 
fusion3 J hybrids were formed between mouse RAG cells which are deficient in hypoxanthine- 
guanine phosphoribosyltransferase (HGPRT) and normal human leukocytes (5).  The Wa and 
JBA hybrid series were isolated in alanosine, adenine hybrid selection medium which selects 
those cells which have APRT activity, usually due  to the presence of  the human gene for 
APRT (6). 2 Alanosine-adenine medium was made by adding alanosine (the gift of Dr. Piero 
Sensi, Lepetit S.p.A.) at a concentration of 7/~g/ml and adenine at 5 X  10  -5 M  in Dulbecco- 
Vogt modified Eagle's minimal medium  (DVME) from Grand Island Biological Co.  (Grand 
Island,  N.  Y.)  supplemented with  10%  fetal calf  serum,  100  U/ml penicillin,  100  /zg/ml 
streptomycin, and 100 #g/ml kanamycin. In the case of the Wa hybrids, the selective system 
operated only against the mouse parent. The hybrids could be distinguished from the human 
parent, however, by their different morphology  (Fig.  1)  and their more rapid, non-contact- 
inhibited growth. The J hybrids were isolated with the HXI?  ~  selective system of Littlefield (7) 
using DVME supplemented with calf serum as above. It should be noted that in the cases 
where the human parent is a  leukocyte,  one need only select against the mouse parent as 
normal leukoeytes do not adhere to the surface of the flask and can be washed away from the 
attached cells. 
Hybrid clones were  isolated,  one colony per bottle,  with stainless steel rings using  the 
method of Puck et al.  (8). These procedures help ensure the independence of each hybrid cell 
strain, the importance of which has been discussed elsewhere (1, 2). Secondary hybrid colonies 
were isolated by plating low cell numbers of primary hybrid strains and picking colonies as 
above.  The  Wa  V  subclones were  isolated  in  medium  containing  2-6-diaminopurine  and 
2-fluoroadenine and thus lacked APRT activity. The details of this back selection are de- 
scribed by Tischfield and Ruddle  2 and are not relevant to the present paper. 
Gel A ssays of Enzymes.--Hybrid clones were examined for the human forms of the following 
22 enzymes by starch gel (9) and acrylamide gel electrophoresis.4 For each gel identification of 
the enzyme, cell extract from 5  X  107 cells was used.  The 22  enzymes are: adenosine  de- 
aminase (EC 3.5.4.4), adenine phosphoribosyltransferase (EC 2.4.2.7), glutamate oxaloacetate 
transaminase (EC  2.6.1.1),  glucose-6-phosphate dehydrogenase (EC  1.1.1.49),  glucose phos- 
phate isomerase (EC  5.3.1.9), hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8), 
isocitrate  dehydrogenase  (EC  1.1.1.42),  indophenol  oxidase-A  [tetrameric  form],  indo- 
phenol  oxidase-B  [dimeric form],  lactate  dehydrogenase-A  (EC  1.1.1.27),  lactate  dehydro- 
genase-B (EC  1.1.1.27),  malate oxidoreductase decarboxylating (EC  1.1.1.40),  malate oxido- 
reductase (EC 1.1.1.37),  mannose phosphate isomerase (EC 5.3.1.8), nucleoside phosphorylase 
(EC  2.4.2.1),  peptidase-A,  peptidase-B,  peptidase-C,  peptidase-D, phosphoglycerate kinase 
(EC 2.7.2.3), phosphoglucomutase-1 (EC 2.7.5.1), and thymidine kinase (2.7.1.21). 
For the starch gel assays of indophenol oxidase, the gels were  stained after  completion of 
2 Tischfield, J., and F. H. Ruddle. Human linkage assignment of adenine phosphoribosyl- 
transferase by means of somatic cell hybridization. Manuscript in preparation. 
3 10-4 M hypoxanthine, 10  -5 M aminopterin, 4 X  10  -a M thymidine, and 10  -'~ M glycine. 
4 Tischfield, J.,  and  F.  H.  Ruddle.  A  new  electrophoretic-autoradiographie method  for 
visualization of phosphotransferases. Submitted to Anal. Biochem. Fro.  1.  Mouse-human somatic cell hybrids of WI-38 and A9 cells against a  background of 
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electrophoresis  with a mixture composed of 5.8 )<  10  -4 M MTT tetrazolium (Sigma Chemical 
Co.,  St.  Louis, Mo.),  1.54 X  10  -4 M  phenazine methosulfate (Sigma  Chemical Co.), and 
8.3  X  10  -2 M Tris HC1 (Sigma Chemical Co.) buffer pH 8.0. Exposure of the stained gel to 
light resulted in the appearance of light bands in a bluish background (Fig. 3). The reaction 
causing  these light bands to appear is catalyzed by the indophenol oxidase activity of the 
cell extracts. This enzyme oxidizes the tetrazolium dye in the presence of phenazine metho- 
sulfate to a  colorless  form. Although  indophenol  oxidase activity is widely distributed  in 
human tissues, little is known of its physiological function in vivo. Two forms of the oxidase 
are analyzed in our study the A (tetrameric) and B (dimerlc) forms. Both forms of the enzyme 
are also known to catalyze the Nadi reaction and the oxidation of dichlorophenolindophenol 
(10). 
Chromosome Analysis.--The human chromosomes were identified in metaphase ceils pre- 
pared to reveal quinacrine banding, Giemsa banding (11), and constitutive heteroehromatin 
(12, 13). To facilitate the identification of chromosomes, metaphases that were photographed 
with ultraviolet illumination for quinacrine mustard banding were also photographed using 
dark-field illumination in the visible spectrum. This resulted in a photograph which clearly 
showed chromosome size and  morphology and which facilitated chromosome identification 
particularly of the small human chromosomes G-21 and G-22. Of the metaphase cells analyzed 
in this study, the majority were prepared as karyotypes. 
Interferon.--We are grateful  to  Dr.  J.  Valenta of  Smith Kline  &  French Laboratories 
(Philadelphia, Pa.) for a gift of unfractionated human leukocyte interferon. This material was 
previously acid treated at pH 2.0 for 72 h. It was then purified on a Sephadex G-150 column 
(2.5 X  94 cm) and eluted at a ve of about 342 ml. Fractions from 350 to 385 ml were pooled 
and dialyzed for 2 days at 4°C against one change of 2 liters DVME without calf serum. Heat- 
inactivated calf serum was added to the pooled interferon fraction to a final concentration of 
10%. Unless othelwise stated, purified interferon was used throughout this study. Similarly, 
mouse serum interferon induced by Newcastle disease virus, Herts strain, was purified on a 
Sephadex G-75 column (2.5  X  45 cm). The partially purified interferons were standardized 
with a  interferon preparation previously standardized to the internal standards for human 
and routine interferon. 
Semi-Microdye-Binding  Assay for A ntiviral State.--Our test for the antiviral resistance in- 
duced by interferon is an adaptation of Armstrong's (14) dye-binding assay for interferon. 
For the assay described here, 0.2 ml of suspended cells  (4 X  104) was placed in each micro- 
well  of a  microtest plate (Linbro Chemical Co., New Haven, Conn.). The microtest plates 
have 96  flat-bottomed wells of 6  mm diameter each. The plates were used for assay 24  h 
after  seeding.  Fluids from  the wells were decanted by  vigorous inversion and  wiped  dry 
with sterile napkins. One set of triplicate wells was used for each concentration of interferon 
used to induce the antiviral state. The volume of partially purified interferon of human  or 
murine origin  added to the microwells was 0.2  ml.  For each cell line induced for  antiviral 
resistance, a  set of triplicate microwells serves as viral control and another set serves as  cell 
control. After incubating the cells overnight with interferon, the roicroplates were decanted 
vigorously, wiped dry with sterile napkins, and challenged with vesicular stomatitis virus 
(VSV) at a  multiplicity of infection (1VIOI) of 2 except where otherwise indicated. The cell 
controls which were not treated with interferon were replenished with 0.2 ml of fresh medium 
per well whereas the viral controls were challenged with VSV. After the viral challenge, the 
cultures were incubated for another 24 h  at which time the viral controls showed 90-100% 
cytopathic effect (CPE)  as observed microscopically and incubation was terminated. Occa- 
sionally,  a longer incubation was required. The plates were decanted and washed twice with 
0.85%  NaC1 before  staining  in  0.5%  methylrosaniline chloride,  5%  formalin  (vol/vol), 
and 5% ethanol (vol/vol) in 0.85% NaC1. The dye was removed by copious washing with 
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by 2-methoxyethanol and read at 550 nm. The amount of antiviral resistance in the inter- 
feron-treated cells is expressed as a percent of the dye extracted from the cell control minus 
the dye extracted from the viral control: 
OD interferon treated -- OD viral control 
x  lOO%. 
OD cell control -- OD viral control 
Species Specificity of Mouse and Human Interferon.--Sets of triplicate microwells of mouse 
8-azaguanine-resistant A9 cells,  WI-38, and an 8-azaguanine-resistant mouse kidney adeno- 
carcinoma cells  (RAG) were incubated with 0.2 ml of mouse (100 U/ml) and human (1,000 
U/ml interferon overnight. The microwells were decanted the next day and challenged with 
VSV. The effect of the viral challenge was read the following day and the results are expressed 
in Table I. The table shows that a strict species specificity barrier exists between mouse and 
human interferon. The hybrid cell line Wa V  (WI-38  X  A9) was protected by both human 
and mouse interferon. 
The Effect of Actinomycin  D on the Induction  of Antiviral Expression by Interferon.--Actino- 
mycin D (Merck Sharp & Dohme, West Point, Pa.), an irreversible inhibitor of DNA-depend- 
TABLE  I 
Species Specificity  of Murine and Human Interferon 
Cell line 
Protection of control 
Mouse interferon*  Human interferon~: 
%  % 
WI-38 (human)  0  94 
A9  (mouse)  102  0 
RAG (mouse)  118  0 
Wa V  (mouse  X  human)  105  112 
*  100 U/ml. 
:~ 1,000 U/ml. 
ent RNA synthesis  was previously shown by Taylor (15) to inhibit the synthesis of an antiviral 
protein in cell cultures induced with interferon. Sets of triplicate microwells of mouse human 
hybrids and parental cells from which these hybrids originated were incubated with 0.2 ml of 
medium  containing mouse or  human  interferon at  concentrations indicated  in  Table  II. 
Actinomycin D  was added to the wells such that the final concentration was 1.2 #g/ml. It 
was added either simultaneously to the wells with interferon or 11  h  after the addition of 
interferon. The concentration of actinomycin D  used in our system inhibited the uptake of 
[14C]uridine (1/zCi/ml, 60 mm culture dish) by 83 and 91% in WI-38 and  A9  cells,  respec- 
tively, after the cells were exposed to the inhibitor for 1 h. The cells were then challenged 
with VSV at an MOI of 5 at h  12. The incubation with virus was terminated at h  30. The 
timing of this experiment is important since actinomycin D causes minor CPE in A9 cells and 
a few of the hybrid cells at 36 h and beyond. 
The effect of actinomycin D  on the induction of antiviral resistance is shown in Table II. 
When the cultures were exposed to actinomycin D simultaneously with interferon, the cultures 
were not resistant to a viral challenge.  However, this effect was greatly reduced when actino- 
mycin D  was added 11  h after the cells were exposed to interferon. The result suggests the 
induction of antiviral resistance by interferon in the hybrid cells is at the transcriptional level. 
Furthermore, the data are consistent with Taylor's observation that interferon induces an 
antiviral protein which is responsible for the antiviral status of the cell (15). 322  HUIV[AN  INTERFERON-INDUCED TRAITS  OF  CI-/RO?cIOSO~IE G-21 
TABLE  II 
The Effect of Actinomyein D on Antiviral State Induced  by Interferon 
Cell line  Type  Actinomycin  Protection of control* 
D added at  Mouse  interferon  Human interferon 
h  ~  % 
WI-38  Human  0  N.D.  0.5 
A9  Mouse  0  0  N.D. 
Wa V  Hybrid  0  1.1  0.8 
Wa III  Hybrid  0  0  N.D. 
J10H9  Hybrid  0  0  0 
WI-38  Human  11  N.D.  N.D. 
A9  Mouse  11  98  N.D. 
Wa V  Hybrid  11  88  93 
Wa III  Hybrid  11  121  N.D. 
J 10H9  Hybrid  11  72  89 
N.D.  =  not done. 
* Control sets of triplicate wells were protected with homologous interferon but not treated 
with actinomycin D, and tile antiviral resistance in these sets were assigned an arbitrary figure 
of 100. The concentrations of mouse and human interferon used was 100 U and 1,000  U/ml, 
respectively, and were added to the cells at h O. 
RESULTS 
A total of 13  mouse-human cell hybrids derived from 13  independent cell 
fusions of mouse and human cells were analyzed for protection by human and 
mouse interferon, and as far as possible, complete chromosomal and enzyme 
analyses were done on these cells simultaneously,. 
The test for antivira] resistance induced by heterologous interferon in these 
mouse-human  cell hybrids shows  that the parental cells from which the hybrids 
were derived  were  protected only by homologous  interferon (Table III). Human 
leukocytes have previously been shown to be protected by human interferon 
(16). Treatment of the hybrid clones with nlouse interferon induced an antivira] 
state in all the hybrids  tested, whereas, treatment of the hybrids  with human 
interferon induced an antiviral state in only  three of the hybrid clones belonging 
to the Wa series (WI-38 X A9) and all of the hybrids of the  J series (human 
lymphocyte  X RAG) and JBA (human lymphocyte  X A9). However,  six hybrid 
clones belonging to the Wa series did not respond to treatment with human in- 
terferon. This loss of sensitivity to protection by human interferon could be in- 
dicative of the loss of a specific  human gene responsible  for the expression  of the 
human antiviral protein. Alternatively, it could suggest the loss of interferon re- 
ceptor sites, but this is unlikely since all the hybrid cells tested were sensitive to 
mouse interferon, and furthermore, they were equally susceptible to VSV chal- 
lenge. 
In testing for the presence  or absence  of the 22 enzymes  examined, the dimeric 
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TABLE  III 
Protection of Somatic Cell Hybrids by Interferon against VSV Challenge 
Cell line  U of interferon/ml 
Protection of control by 
Human interferon  Mouse interferon 
%  % 
WI-38XA9 
Wa I  1,000  57  69 
100  42  98 
Wa II  1,000  41  93 
100  29  112 
Wa III  1,000  0  76 
100  0  87 
Wa IV  1,000  0  83 
100  2  101 
WaV  1,000  132  93 
100  104  100 
10  39  83 
Wa VI  500  3  100 
100  0  104 
Wa VII  1,000  0  77 
100  1  89 
Wa VIII  1,000  4  94 
100  0  102 
Wa IX  1,000  6  94 
100  0  94 
WI-38  1,000  112  1.8 
100  77  N.D. 
A9  1,000  0.8  98 
Human leukocyte X 
A9 
JBA-1  1,000  89  87 
100  12  N.D. 
Human leukocyte X 
RAG 
J3S  200  N.D.  65 
20  62  43 
Jl0H9  200  99  106 
20  98  111 
Jl0H7  200  104  96 
20  98  96 
N.D.  =  not done. 
segregated concordantly with protection by human  interferon (Table IV). Chro- 
mosomal analysis was done for 12 of the 13 primary clones. The number of meta- 
phases examined for the chromosomal  analysis is also indicated.  Chromosome 
G-21 was the only chromosome which was detected in all clones which were pro- 324  HUMAN  INTERFERON-INDUCED  TRAITS OF CHROMOSOME  O-21 
TABLE IV 
The  Segregation  of  Antiviral  Protein  (A VP)  Indophenol  Oxidase  (IPO-B)  and  Ituman 
Chromosome G-g1 in Primary Clones 
Hybrid clone  no. of metaphases  no. of metaphases  IPO-B  AVP 
analyzed  showing G-21 
Wa Ia  23  13  +  + 
Wa IIa  32  21  +  + 
Wa III  50  0  -  - 
Wa IVa  29  0  -  - 
Wa V  59  31  +  + 
Wa Via  58  0  --  -- 
Wa VIIa  48  0  --  -- 
Wa VIIIa  31  0  --  -- 
Wa IXa  27  0  --  -- 
JBA-1  55  42  +  + 
JaS  I0  10  +  + 
JloH9  27  13  +  + 
J10H7  N.D.  N.D.  +  + 
+,  indicates phenotype present; --, indicates phenotype absent. 
tected by human interferon and which contained the human  form  of indophe- 
nol oxidase (Table IV). Table IV also shows an average frequency of 63 %  for 
chromosome G-21 in those clones which retained both the AVP and IPO-B hu- 
man phenotypes. Among the clones not showing the two phenotypes  the fre- 
quency of G-21 chromosome was 0%. 
From the chromosomal analysis of those clones which showed both pheno- 
types (AVP and IPO-B), it was determined that Wa V  contained the smallest 
number of human chromosomes. It seemed reasonable that Wa V  was our best 
candidate for providing further evidence for or against the synteny of IPO to 
AVP and the linkage of both phenotypes to chromosome G-21. Wa V cells were, 
therefore, subjected to a back selection procedure using l, 6-diaminopurine and 
2-fluoroadenine resulting in further loss of human chromosomes in these cells3 
This back selection method, selects for those cells which have lost APRT  and, 
therefore, continue to grow in the presence of 2,6-diaminopurine and 2-fluoro- 
adenine. A total of nine subclones were isolated after a period of a month by this 
procedure. These subclones were exposed to mouse and human interferon. The 
results in Table V  show all the nine subclones were protected by mouse inter- 
feron. All nine subclones but one (Wa V  R4c) were protected by human inter- 
feron. The eight that were protected by human interferon also expressed the di- 
meric form of human  indophenol  oxidase  (Table VI). However,  the  subclone 
(Wa V R4c) which lost the AVP phenotype also lost IPO-B phenotype. A com- 
plete chromosomal analysis of four of the nine subclones isolated indicates the 
clones which  retained  both  human  phenotypes  had  an  average frequency  of 
68.7 %  cells retaining the G-21 chromosome and 0%  in the case of Wa V  R4c 
which had lost both phenotypes (Table VI). Y.  H.  TAN, J.  TISCHFIELD,  AND  1  ~.  H.  RUDDLE 
TABLE  V 
Protection  of Wa V Subclones by Interferon  against  VSV Challenge 
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Cell type  U of interferon/ml 
Protection by 
Human interferon  Mouse interferon 
%  % 
Wa V 2Ra  1,000  91 
100  92  86 
Wa V 2Rb  1,000  87 
100  66  97 
Wa V 4Ra  1,000  68 
100  57  104 
Wa V 4Rb  1,000  77 
100  65  78 
Wa V 4Re  1,000  0 
100  0  98 
Wa V 4Rd  1,000  38 
100  44  69 
Wa V 5Ra  1,000  86 
100  77  77 
Wa V 5Rb  1,000  46 
100  28  89 
Wa V 5Re  1,000  72 
100  41  101 
TABLE  VI 
The Segregation  of Antiviral Protein, Indophenol  Oxidase,  and  Human  Chromosome  G-21 in 
Subdones  of Wa V 
Subclones  no. of metaphases  no. of metaphases  IPO-B  AVP 
analyzed  showing G-21 
Wa V R4c  69  0  --  -- 
Wa V R4d  27  19  +  + 
Wa V R5b  25  18  +  + 
Wa V R2b  25  16  +  + 
Wa V R2a  N.D.  N.D.  +  + 
Wa V R4a  N.D.  N.D.  +  + 
Wa V R4b  N.D.  N.D.  +  + 
Wa V RSa  N.D.  N.D.  +  + 
Wa V RSc  N.D.  N.D.  +  + 
N.D.  =  not done. 
+, indicates phenotype present; --, indicates phenotype absent. 
The loss of the G-21 chromosome in Wa V  R4c is clearly shown in the repre- 
sentative metaphases of the Wa V  subclones (Figs. 2 a  and b). Correspondingly, 
the loss of IPO-B phenotype  from Wa V  R4c is clearly indicated in the starch gel 
stained for IPO-B (Fig. 3). The simultaneous loss of AVP, IPO-B human pheno- 326  HUMAN  INTERFERON-INDUCED  TRAITS  OF  CHROMOSOME  G-21 
FIG.  2.  (a) Karyotypes of Wa V  R4c and RSb; (b) karyotypes of Wa V  R4d and R2b. 
type, and genotype G-21 in subclone Wa V R4c support the synteny of the hu- 
man genes for IPO-B and AVP and their linkage to the G-21 chromosome. 
It is also possible to strengthen the proposed assignments by the demonstra- 
tion  of  negative  correlations  between  the  IPO-B  and  AVP  phenotypes  and 
chromosome other  than  21.  Such negative correlations exist between the  two 
phenotypes and all the chromosomes except 21  (Table VII). These negative re- 
sults in addition to the positive correlation strongly support the suggested chro- 
mosome assignment. 
DISCUSSION 
Previous to this study, little was known of the genetics of the  interferon sys- 
tem except that the structural gene for the synthesis of interferon is located on a 
locus separate from that coding for the synthesis of antiviral protein  (17-19). Y.  H.  TAN~ J.  TISCHFIELD~ AND  F.  H.  RUDDLE  327 
FIG. 3.  Zymogram showing IPO-B activities of Wa V subclones. 
Using  monkey-mouse hybrid  cells,  Cassingena  et  al.  (19)  suggested  that  the 
genome governing the synthesis  of simian  interferon-induced  AVP possibly is 
located in one of the VSST (very very small subtelocentric  of simian origin) or 
on  a  VLSM  chromosomes  (very  large  submetacentric  of  simian  or  murine 
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TABLE  VII 
Negative Correlation  of Indophenol  Oxidase and Antiviral  Protein  with  Chromosomes  Other 
Than G-21 
ttuman  Human phenotype IPO-B and AVP /  Human chromosome  chromosome 
+/+  -/-  +/-  -/+ 
1  3  6  6  1 
2  1  6  8  1 
3  2  6  7  1 
4  7  7  2  0 
5  0  7  9  0 
6  0  6  9  1 
7  3  6  6  1 
8  3  6  6  1 
9  0  7  9  0 
10  3  6  6  1 
11  3  6  6  1 
12  3  5  6  2 
13  1  6  8  1 
14  l  4  8  3 
15  0  7  9  0 
16  4  3  5  4 
17  2  7  7  0 
18  4  7  5  0 
19  2  7  7  0 
20  5  6  4  1 
21  9  7  0  0 
22  5  3  4  4 
X  4  5  5  2 
+  =  present;-  =  absent. 
In our present study, we also examined the ability of hybrid clones of the Wa 
series to synthesized interferon. Primary clones of the Wa series were exposed to 
inducers of interferon such as Newcastle disease virus (NDV)  at an MOI of 1 
and to poly I-poly C (100 and 200 #g/ml from P. L. Biochemicals, Milwaukee, 
Wis.) for 1 h. However, none of the hybrid clones of  the Wa series was  shown 
to produce any human interferon although all of them produced between 8 and 
24 U of mouse interferon from each culture dish in response to NDV stimulation. 
In view of the observation that three of the Wa primary clones are protected by 
human interferon (Table III), the data are in agreement with the hypothesis 
that the genes for interferon synthesis and AVP s~mthesis are located in different 
chromosomes. 
From our present study, we have traced the concordant segregation of AVP 
and IPO-B in the 13 primary mouse-human hybrids and nine subclones (Tables 
IV and VI). The simultaneous disappearance of AVP and IPO-B in one of the 
nine subclones of Wa V  (Table VI) provides further evidence for the synteny of Y.  It.  TAN, .]'. TISCHFIELD,  AND  F.  H.  RUDDLE  329 
the two phenotypes. Additional evidence in support of this hypothesis comes 
from the observation that there were strong negative correlations between the 
two human phenotypes and all of the human chromosomes except for chromo- 
some  B4 for which  there is  a  weaker negative correlation  (Table VII).  One 
primary clone J10H9 and one subclone Wa V R2b, however, rule out the possi- 
bility of linkage to B4 since in a total of 52 metaphases examined, none had a B4 
chromosome; whereas,  56%  of  the  cells  examined possessed  a  human  G-21 
(Tables IV and VI). 
The assignment of AVP to chromosome G-21, we believe, represents the first 
mapping of a  genetic factor regulating an inducible phenotype in mammalian 
cells. The evidence suggesting that AVP is an inducible phenotype comes from 
the use of actinomycin D  in our system. Exposure of those hybrid cells (Table 
II) which were protected by human interferon to actinomycin D  at the time of 
interferon addition eliminated the protection. However, once the antiviral state 
is induced in these cells by human interferon, actinomycin D was no longer effec- 
tive. 
SUMMARY 
13 independent mouse-human somatic cell hybrid clones derived from ~-pro- 
piolactone-inactivated Sendal stimulated cell fusion of human cells with mouse 
cells were tested for their sensitivities to human and mouse interferon. All of 
them were protected by mouse interferon and only six of the clones were pro- 
tected by both human and mouse interferon. Only the six that were protected 
by human interferon were shown to express the human dimeric form of indo- 
phenol oxidase. Complete chromosomal analysis of the clones indicated human 
chromosome G-21  to be the only human chromosome in common for the six 
clones which had both phenotypes present. Nine subclones were derived from 
one of the clones expressing both phenotypes. Eight of the nine subclones were 
shown to retain both phenotypes, whereas one subclone lost both. Chromosomal 
analysis of the subclones indicated the loss of chromosome G-21 from the sub- 
clone which lost both phenotypes. It is apparent from these findings that the 
gene(s)  for indophenol oxidase (IPO-B) and the gene(s) for the antiviral  pro- 
tein are syntenic and that they are linked to human chromosome G-21. 
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